Advertisement
Canada markets close in 5 hours 53 minutes
  • S&P/TSX

    21,858.17
    +149.73 (+0.69%)
     
  • S&P 500

    5,012.57
    +1.45 (+0.03%)
     
  • DOW

    37,985.69
    +210.31 (+0.56%)
     
  • CAD/USD

    0.7280
    +0.0016 (+0.22%)
     
  • CRUDE OIL

    82.78
    +0.05 (+0.06%)
     
  • Bitcoin CAD

    89,292.73
    +3,161.21 (+3.67%)
     
  • CMC Crypto 200

    1,383.19
    +70.56 (+5.69%)
     
  • GOLD FUTURES

    2,396.20
    -1.80 (-0.08%)
     
  • RUSSELL 2000

    1,950.46
    +7.51 (+0.39%)
     
  • 10-Yr Bond

    4.6130
    -0.0340 (-0.73%)
     
  • NASDAQ

    15,533.74
    -67.76 (-0.43%)
     
  • VOLATILITY

    18.39
    +0.39 (+2.17%)
     
  • FTSE

    7,853.09
    -23.96 (-0.30%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6820
    -0.0001 (-0.01%)
     

Stocks in play: Intellipharmaceutics International Inc.

Announced today that its financial statements for the interim period ended May 31, 2022 and related management's discussion and analysis and accompanying Chief Executive Officer and Chief Financial Officer certificates due July 15, will not be filed by the Filing Deadline. Intellipharmaceutics International Inc. shares T.IPCI are trading unchanged at $0.12.

Read: